key: cord-0736729-dzs3dm0f
authors: Sharma, Priyanka; Khokhar, Anita
title: Risk factors and perceptions about coronavirus disease among tuberculosis patients in Delhi, India: a cross-sectional study
date: 2021-10-13
journal: Indian J Tuberc
DOI: 10.1016/j.ijtb.2021.10.006
sha: b832349decbd8241dbe73ddcc34521014145e5b2
doc_id: 736729
cord_uid: dzs3dm0f

BACKGROUND: Tuberculosis (TB) and Coronavirus disease (COVID-19) co-infection can increase the severity among affected patients. This study was conducted to study the burden, risk factors and perceptions of COVID-19 among TB patients. METHODS: This was a cross-sectional study conducted among TB patients at one of the Directly Observed Short Course (DOTS) centre of Urban Primary Health Centre (UPHC) of Delhi, India. Information regarding socio-demographic profile, TB disease profile, history of COVID-19 and perceptions about TB and COVID-19 co-infection was collected. Descriptive analysis was performed. RESULTS: A total of 107 study participants were enrolled. Twenty-two TB patients (20.6%) never got tested for COVID-19. Two TB patients out of 107 study participants had COVID-19 in past. Both were males in age group of 30-44 years, had drug sensitive TB and were having pre-existing co-morbidities. Transmission routes of TB and COVID-19 were not known to about half of the study participants. Approximately 42.1% study participants perceived TB patients to be at higher risk of COVID-19 and majority study participants agreed that they should follow COVID-19 appropriate behaviour. However, helpline numbers for COVID-19 were not known to most of the study participants. CONCLUSION: One-fifth of TB patients were never tested for COVID-19 inspite of the bi-directional screening guidelines for TB patients. Guidelines need to be practised stringently to find out true burden of co-infection. As the two TB patients who had COVID-19 in past already had other co-existing co-morbidities as risk factors, whether TB enhances the risk for coronavirus infection independently needs further research.

In the year 2019, an estimated 10 million people fell ill with tuberculosis across the globe.

South-East Asian region accounted for 44% of the global incidence. A reduction of 2.3% in incidence rate was noted between 2018 and 2019. There were an estimated 1.4 million TB deaths in world in 2019. The cumulative reduction in annual TB deaths was between 2015 to 2019 was 14%. India contributed 26% to the global burden of this disease. [1] COVID-19 pandemic, started in December 2019, has devastated many countries in the world.

As of 2 nd March, 2021, there were more than 113 million confirmed COVID-19 cases and 2.5 million deaths globally. India ranked second in terms of total cases and fourth in terms of total deaths during the same time period. [2] There is a threat that this pandemic could reverse the progress made in reduction of global TB burden. During 6-month period from January to June 2020, the overall reductions in reported number of people diagnosed with TB compared to the same period in the year 2019 were in the range 25-30% in few countries including India. This could substantially increase annual number of TB deaths. [1] TB and COVID-19 are both respiratory infections affecting lungs but with slightly different routes of transmission. Infection control measures required for both these diseases are same including cough etiquette, handwashing, social distancing, regular cleaning of surfaces, prolonged quarantine, isolation and use of masks. [3] There is limited evidence relating to increased severity of COVID-19 among TB patients. The prevalence of TB among patients J o u r n a l P r e -p r o o f with COVID-19 has ranged from 0.37 to 4.47% in different studies. [4] Early reports show TB infection increases susceptibility to COVID-19 and its severity. [4] [5] TB was found to be associated with 2.1 times increased risk of severe COVID-19 disease. [4] There is also a possibility that both TB and COVID-19 could exacerbate natural symptoms of other's and have negative impact on individual's health. [5] To counter this double menace of TB and 

Semi-structured interviewer-administered questionnaire was used to gather information from study participants regarding socio-demographic profile of patient, TB disease profile, history of COVID-19 infection and testing in patient and perceptions about TB and COVID-19 coinfection. Socio-economic status was calculated using modified B. G. Prasad scale, which takes into account monthly per capita income, updated for the year 2020. [7] The questionnaire was pre-tested among 15 TB patients and was modified as per the findings from pre-testing. The data from pre-testing were not included in the final analysis.

TB patients and their family members who came to collect medications from DOTS centre of the UPHC, were assessed for eligibility as per inclusion criteria. They were then invited to participate in the study and were explained the nature and purpose of the study. Informed consent was obtained from them. Thereafter, face-to-face interviews were conducted with study participants. Details related to TB disease profile were recorded from patient's J o u r n a l P r e -p r o o f treatment card available with patients and their family members. COVID-19 related information of the patient and perceptions were then asked from either the TB patients themselves or from their family members. Convenient sampling technique was used to include the study participants. All TB patients who were included in study and had themselves came to collect their medications were also asked to undertake rapid antigen testing available at no cost at UPHC. TB patients who were symptomatic, after undertaking test and testing negative, were asked to visit Medical Officer of the UPHC for further evaluation, treatment and management.

The data were entered into MS excel and analysed using SPSS. Descriptive analysis was performed. Categorical data were presented as frequencies and percentages and continuous data as mean. Random blood sugar at time of diagnosis was categorised as normal for levels of <140mg/dl, impaired if it was ≥140mg/dl but less than 200mg/dl and diabetic if it was ≥200mg/dl. [8] Ethics

The study was conducted within the boundaries of Helsinki declaration. Permission to conduct study was obtained from institutional review board of the authors' institution.

Informed consent was obtained from participants aged ≥18years, family members of paediatric TB patients and those who had come to collect medications on behalf of TB patient. Assent was obtained from TB patients of age ≤14years. Privacy and confidentiality of data was ensured.

A total of 107 study participants were included in the study out of which 71 (66.4%) were patients themselves and 36 (33.6%) were first-degree family members of TB patients. Mean J o u r n a l P r e -p r o o f age of TB patients was 30.9±15.4years (Range 6-68years). Mean weight of adult TB patients at time of diagnosis was 47.0±10.8Kg (Range 25-90Kg) and of paediatric TB patients was 31.7±12.1Kg (Range 12-50Kg).

Thirteen (12.1%) patients were paediatric TB cases and rest (87.9%, 94) were adults.

Approximately 43.9% (47) were illiterate. About one-fourth TB patients (24.3%, 26) had some pre-existing co-morbidity and the most common co-morbidity was diabetes, followed by obesity and hypertension. (Table 01) Majority TB patients were new cases (78.5%, 84) and had drug sensitive disease (90.7%, 97).

Human Immunodeficiency Virus (HIV) infection prevalence among TB patients was 0.9%

(1). Thirty-four (31.8%) patients were ever tobacco users. Two patients (1.8%) had RBS levels at time of diagnosis in impaired range and 8 (7.5%) already diagnosed diabetic patients had their RBS levels ≥200mg/dl. (Table 02) One-fourth study participants (25.2%, 27) had one or more symptom of COVID-19 in last two weeks and the most common symptom was cough. About 79.4% (85) TB patients had ever got tested for COVID-19 and most of them (70.6%, 60) were last tested more than one month back. (Table 02) Only two patients had COVID-19 in past. Both were males, non-smokers, in age group of 30-44 years, and were having drug-sensitive TB. Out of them, one had COVID-19 before being diagnosed as pulmonary TB re-treatment case and was a known diabetic. The patient had uncontrolled diabetes at the time of diagnosis of TB and was having drug sensitive TB. One of his family member also developed COVID-19 later. The other one had it during the course of TB illness, and was a chronic kidney disease patient undergoing dialysis. He was having extra-pulmonary TB and was a new case.

According to study participants, the most common mode of transmission for TB was by sharing the food followed by respiratory route while for COVID-19 was respiratory route followed by touch. However, 51.4% (55) give consent for testing. The most common reasons for this were a recent COVID-19 test within past one month and not having any symptoms at present.

The literature relating to TB and COVID-19 is limited in the country, but both infections affect the common organ, lungs and mode of transmission is slightly different. Nonetheless the infection control and preventive measures are more or less similar for both these diseases.

This study therefore attempted to study the risk factors of COVID-19 among TB patients and their perceptions about the co-infection to aid in preventing co-occurrence of these diseases.

Out of 107 TB patients, 20.6% were never tested for COVID-19. Amongst those who were ever tested, mostly had their last COVID-19 test done more than 1 month back. As per guidelines from Ministry of Health and Family Welfare, Government of India, bi-directional screening is to be performed amongst all the patients of TB for COVID-19 and all COVID-19 patients who are symptomatic for TB. [4] This is essential to find out the true burden of co-J o u r n a l P r e -p r o o f infection as many symptoms for the two diseases overlap and might obscure the diagnosis of other, leading to delay in treatment initiation and increase in severity and complications.

Missing the opportunity to test such patients for other infection could also aid in continued transmission of infection in the community. Therefore, the medical officers, the staff employed at DOTS centre, the personnel involved in testing patients for COVID-19 at the UPHC were sensitized about the co-infection of TB and COVID-19 and importance of bidirectional screening, after completion of the study. All the patients coming to DOTS centre

were then counselled to get tested for COVID-19 and people getting tested for COVID-19 who had symptoms suggestive of TB were advised to get tested for TB at the DOTS centre.

In present study, two TB patients ever had COVID-19. COVID-19 developed during the course of TB treatment in one patient and before the diagnosis of TB in another patient, though he had been treated for TB in past also. This was in tune with the findings of previous studies [9] [10] which concluded that COVID-19 can occur before, during or after the diagnosis of TB. There is usually some left-over damage in lungs post TB which might put TB survivors at high risk of severe COVID-19. [5] However, role of COVID-19 in development of active TB is yet to be ascertained. [9] TB patients tend to have co-morbid conditions which further increase their vulnerability to coronavirus infection. [4] This was reiterated in our study as the two patients in present study who had COVID-19 in past had other existing co-morbidities (diabetes and chronic kidney disease). Previous studies have shown that diabetic individuals have three times more risk of having severe symptoms or die from COVID-19. [11] Also, both DM and CKD have been implicated as risk factors for severe COVID-19. [12] Whether the prevalence of COVID-19 found in present study could be attributed to TB or to pre-existing co-morbidities could not be commented upon and requires future research. infection and about two-third (64.5%) were of view that COVID-19 co-infection can increase complications among TB patients. As the early evidence showed increased negative health effects of TB and COVID-19 co-infection, it is important to make people aware about it through enhanced awareness campaigns. However, whether COVID-19 co-infection can have any effect on anti-TB treatment (ATT) was not known to about 59.8% study participants. It has been anticipated that co-infection with COVID-19 among TB patients can lead to more severe outcomes if ATT is discontinued and will lead to continued TB infection transmission in community. [3] [18] The importance of continuing ATT even in cases of co-infection should be stressed upon [4] [18] and communicated to TB patients and their family members.

Majority of the study participants answered affirmatively when asked should TB patients should COVID-19 appropriate behaviour to prevent co-infection. COVID-19 appropriate J o u r n a l P r e -p r o o f behaviour should not be compromised by TB patients even if they are on treatment for TB as impact of COVID-19 on people with TB and on treatment is not yet completely known. [5] However, approximately half of the study participants said that COVID-19 related any information should be shared without verification. In this era of infodemic, misinformation spreads speedily. Misinformation contributes to spread of COVID-19, might increase fear, lead to social disaccord, and can also cause direct damage by delaying care-seeking, or wrong medical treatment. [19, 20] Quality-information guided citizen actions are crucial for the successful global response to this pandemic. [21] Public should be educated about the illeffects of misinformation and should be encouraged to verify any information before circulating it on social media or other media channels. Helpline numbers should be more aggressively communicated as majority study participants were not aware of any helpline numbers for COVID-19, which could be due to high rates of illiteracy in present study. These helplines can also be used to counter myths related to co-infection and disseminate correct information. Frequent health talks were organized at the UPHC to spread awareness about COVID-19 and dangers of mis-information. TB patients and their family members visiting DOTS centre at the UPHC were also sensitized regularly about the possibility and complications associated with co-infection, importance of treatment compliance and covid appropriate behaviour.

Only one-fifth (22.4%) study participants knew that tobacco use increases the risk of both TB and COVID-19 and 31.8% were ever tobacco users. Tobacco is an independent risk factor of TB [5] [22] [23] and evidence has shown smoking increases the risk of COVID-19. [5] Therefore, tobacco cessation programs and centres are vital to address this problem and can reduce the burden of both the infections. TB and COVID-19 patients should be counselled to quit tobacco as it can improve the treatment outcome and decrease the disease severity for both infections. [5] [23] A non-communicable diseases (NCD) clinic is functional at the J o u r n a l P r e -p r o o f UPHC for early screening, prevention and control of common NCDs. Tobacco cessation counselling is an integral part of this NCD clinic and tobacco users are regularly counselled about quitting tobacco.

Strengths-To the best of our knowledge, this is amongst the few early studies conducted to assess the burden, risk factors and perceptions about COVID-19 among TB patients in India.

Face-to-face interviews were conducted thereby reducing selection bias inherent in online surveys. Information was collected by a single investigator so information bias was minimized.

Limitations-There are few limitations of the present study. It was a cross-sectional study so temporal relationship could not be established. The sample size was small and study population comprised of semi-urban population from a single DOTS centre. Therefore, findings cannot be generalised to other sections of population. There is also a possibility of recall bias. As some of the data were self-reported, reporting bias couldn't be ruled out.

One-fifth of TB patients were never tested for COVID-19 inspite of the bi-directional screening guidelines for TB patients. Guidelines need to be practised stringently to find out true burden of co-infection. As the TB patients who had COVID-19 in past already had other co-existing co-morbidities, whether TB enhances the risk for COVID-19 independently needs further research. Approximately 42.1% study participants perceived TB patients to be at higher risk of COVID-19, they should be made aware about severity of co-infection and whom to contact in case of symptoms suggestive of COVID-19. Majority agreed that TB patients should keep following COVID-19 appropriate behaviour but more than half acknowledged that COVID-19 related information should be shared without verification.

Therefore, harms of mis-information should be communicated to them. J o u r n a l P r e -p r o o f 

Executive Summery. World Health Organization

COVID-19) Dashboard. World Health Organization

Tuberculosis and COVID-19 in India: Challenges and opportunities

Guidance note on bi-directional TB-COVID screening and screening of TB among ILI / SARI cases. Ministry of Health and Family Welfare, Government of India

Frequently Asked Questions: COVID-19 and Tuberculosis. Version 2. The Union

How to calculate sample size for different study designs in medical research?

Updated BG Prasad Socio-Economic Classification: The 2020 Update

ICMR Guidelines for Management of Type 2 Diabetes

Active tuberculosis, sequelae and COVID-19 co-infection: First cohort of 49 cases

A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis

Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome

Centers for Disease Control and Prevention. COVID-19

Awareness about tuberculosis and RNTCP services among rural people in Nalgonda district

Knowledge, attitude, and practices towards tuberculosis among clients visiting tepi general hospital outpatient departments

A cross-sectional survey of knowledge, attitude, and practices (kap) toward pandemic COVID-19 among the general population of

Assessment of knowledge gaps and perceptions about COVID-19 among health care workers and general public-national cross-sectional study

Increasing public awareness is vital in the fight against infectious diseases. Science Daily. 29 th

World Health Organization ( WHO ) Information Note. Tuberculosis and COVID-19

COVID-19 : Considerations for tuberculosis ( TB ) care. World Health Organization

pdf?sfvrsn=554b68a7_0#:~:text=COVID-19%3A Considerations for tuberculosis (TB) care,-As the world&text=Modelling work suggests that if

COVID-19: the medium is the message

Who falls for fake news? The roles of bullshit receptivity, overclaiming, familiarity, and analytic thinking

An exploratory study of COVID-19 misinformation on Twitter

World Health Organization

World Health Organization. Tuberculosis & tobacco. World Health Organization

Authors would like to acknowledge all the study participants for their valuable time.

Source of funding: None